Navigation Links
Regeneron Announces September 2012 Investor Conference Presentations
Date:8/29/2012

TARRYTOWN, N.Y., Aug. 29, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations at the following investor conferences:

  • Robert W. Baird Healthcare Conference at 1:20 p.m. Eastern Time on Wednesday, September 5, 2012
  • Morgan Stanley Global Healthcare Conference at 3:55 p.m. Eastern Time on Tuesday, September 11, 2012
  • UBS Global Life Sciences Conference at 7:30 a.m. Eastern Time on Thursday, September 20, 2012
  • The sessions may be accessed through the Company's web site, www.regeneron.com, on the Events and Presentations page.  Archived versions of the presentations will be available for thirty days after the live webcasts. 

    Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets three products in the United States, EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection for Subcutaneous Use.  Regeneron has filed a regulatory application with the U.S. Food and Drug Administration (FDA) for a second indication for EYLEA.  Phase 3 studies are in progress with EYLEA in two additional indications and with product candidates sarilumab and REGN727.  Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.  Additional information and recent news releases are available on the Regeneron web site at www.regeneron.com.Contact Information:Manisha Narasimhan, Ph.D.

    Peter DworkinInvestor Relations

    Corporate Communications914-847-5126

    914.847.764manisha.narasimhan@regeneron.com 

    peter.dworkin@regeneron.com


    '/>"/>
    SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
    2. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
    3. Regeneron Announces June 2012 Investor Conference Presentations
    4. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
    5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
    6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
    7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
    8. Misonix Announces New Distribution Agreement For Panama
    9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
    10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2019)... ... August 21, 2019 , ... Dr. Leonard Bley ... their newest laser ReLEx® SMILE (Small Incision Lenticule Extraction) located in their state-of-the-art Manhattan ... and SMILE in the Tri-State area. SMILE is a one-step, one laser procedure that ...
    (Date:8/21/2019)... Israel (PRWEB) , ... August 21, 2019 , ... ... entering into a partnership to enhance cybersecurity workforce education and training. To commence ... simulated training platform for cybersecurity practitioners. Businesses in the United States now have ...
    (Date:8/21/2019)... ... August 21, 2019 , ... Impact Advisors , a leading provider of ... it has been named to Inc. magazine’s Inc. 5000 list. The Inc. 5000 list ... significant percentage revenue growth. This year the firm was also named a 5-Time Inc. ...
    Breaking Medicine Technology:
    (Date:8/21/2019)... ... August 21, 2019 , ... ... x-ray inspection technology: HDRX imaging. HDRX captures extremely high-resolution images of products ... can deliver high image resolution at normal production line speeds within power ...
    (Date:8/19/2019)... LOUISVILLE, Ky. (PRWEB) , ... August 19, 2019 , ... ... prevent on-ice injuries through preventative physical therapy and to access to top-notch sports medical ... a PT group that understand the physical demands of ice skating, knows the individualized ...
    (Date:8/17/2019)... ... 17, 2019 , ... Approximately 50 area youth between the ... a program sponsored by United Concordia Dental and Mission Arlington/Metroplex. , “We value ... to make these services available to area youths who are uninsured or underinsured,” ...
    (Date:8/16/2019)... ... August 16, 2019 , ... ... handcrafted, one-of-a-kind children’s aircraft to Ronald McDonald House Charities in New Hyde Park, ... residents undergoing medical treatments and their family members a comfortable and fun way ...
    (Date:8/15/2019)... (PRWEB) , ... August 15, 2019 , ... With many students either starting college for ... for this particular demographic. According to the CDC , “there are about 20 million ... are in people between the ages of 15 and 24. Young people are at greater ...
    Breaking Medicine News(10 mins):